Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19
Clinical trial NCT04527575 · COMPLETED
Trial details
- NCT number
- NCT04527575
- Sponsor
- Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2021-12-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.